Regional News Archives - Page 173 of 188 - Journal for Clinical Studies

Current Edition

news

FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease

The U.S. Food and Drug Administration approved Onpattro (patisiran) infusion for the treatment of peripheral nerve disease (polyneuropathy) caused by hereditary tran...

22 August 2018 news | North America | Regional News

Continue Reading →

news

Oxford Genetics signs major supply and licensing agreement for CRISPR engineered mammalian cell lines

Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has secured a multi-million pound cont...

9 August 2018 news | Regional News

Continue Reading →

news

Quanticate Names David Hukin Senior Director of Pharmacovigilance

London, UK, Quanticate, a leading global data-focused clinical research organisation (CRO) has named David Hukin as the company's new Senior Director of Pharmacovigil...

9 August 2018 news | Regional News

Continue Reading →

news

Cellect Granted Key European Patent for Its Stem Cell Selection Technology

Through negative selection, Cellect's technology identifies mature cells that can be harmful to the recipient and selectively eliminates those cells through apoptosis...

9 August 2018 news | Regional News

Continue Reading →

Asia Pacific

HUJI gets an ultra-high resolution U-CT system

The researchers at Blum Lab will be using the MILabs’ ultra-high resolution CT to detect novel gold labeled probes in cancerous tissue as well as in atherosclerotic p...

Continue Reading →

Europe

Veeva Vault eTMF Helps Cancer Research UK Improve Clinical Trial Efficiency and Compliance

Leading charity modernizes trial operations to develop new cancer treatments faster BARCELONA, Spain — 13 September 2017 — Veeva Systems announced today that Cancer ...

13 September 2017 Europe | news | Regional News

Continue Reading →

Europe

Ferring Pharmaceuticals: The Scottish Medicines Consortium Approves Use of NOQDIRNA® (oral lyophilisate desmopressin), the First Licensed Treatment for Nocturia due to Idiopathic Nocturnal Polyuria in Adults

The Scottish Medicines Consortium (SMC) has announced today a positive decision for the use of NOQDIRNA®. NOQDIRNA® is the only licensed treatment for the sympto...

9 August 2017 Europe | news | Regional News

Continue Reading →

Europe

Antidepressant use increases risk of head injuries among persons with Alzheimer’s disease

Antidepressant use is associated with an increased risk of head injuries and traumatic brain injuries among persons with Alzheimer’s disease, according to a new study...

9 August 2017 Europe | news | Regional News

Continue Reading →

Asia Pacific

WuXi AppTec Immunotherapy Report: Biotech Sector Will Drive Biggest Advancements in Decades on Cancer Treatments

Small nimble biotechs to introduce a ‘golden age’ of next generation therapies like CAR-T, combination therapies, innate immune system approaches, and newer check-poi...

9 August 2017 Asia Pacific | news | Regional News

Continue Reading →

Europe

CPhI Annual Reports – how accurate were they 5 years on?

The CPhI predictions foresaw advancement in QbD, continuous processing, and a dramatic rise in FDA warning letters Amsterdam, 27 July 2017: CPhI Worldwide, organized ...

27 July 2017 Europe | news | Regional News

Continue Reading →